Drug Topics April 22, 2024
Lauren Massaro

Karen Fancher, PharmD, addresses how hearing the perspectives of colleagues can offer invaluable support to shape individualized approaches to ethical dilemmas in oncology pharmacy.

Just as in any ethical dilemma, there’s no one-size-fits-all answer to guide the ethical considerations and decision-making processes of oncology pharmacists. Factors such as illness severity, prognosis, patient wishes, and family input all play a role in charting a patient’s path forward. According to Karen Fancher, PharmD, taking a personalized approach ensures that each patient receives the best possible care.

“I feel that we have some patients that are very severely ill, but are going to be cured,” said Fancher. “[For that patient, oncology pharmacists might take] a different approach than to a patient who is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Pharma, Pharma / Biotech, Trends
Novartis to acquire radiopharmaceutical firm Mariana Oncology for up to $1.75B
Amgen shares soar as executives outline obesity drug push
A closer look at 2023's top biopharma deals and what lies ahead
Amid buzz for Amgen's obesity drug, company sees revenue boost
Fierce Pharma Asia—Ono buys Deciphera for $2.4B; Novartis expands PeptiDream collab; WuXi Bio exits BIO 2024

Share This Article